Maternal, fetal, and neonatal toxicity and potency estimates of perfluorohexane sulfonate (PFHxS) from oral maternal exposure in the Sprague-Dawley rat
Justin M. Conley , Christy S. Lambright , Nicola Evans , Jacqueline Bangma , Jermaine Ford , Donna Hill , Elizabeth Medlock Kakaley , L. Earl Gray Jr.
{"title":"Maternal, fetal, and neonatal toxicity and potency estimates of perfluorohexane sulfonate (PFHxS) from oral maternal exposure in the Sprague-Dawley rat","authors":"Justin M. Conley , Christy S. Lambright , Nicola Evans , Jacqueline Bangma , Jermaine Ford , Donna Hill , Elizabeth Medlock Kakaley , L. Earl Gray Jr.","doi":"10.1016/j.tox.2025.154245","DOIUrl":null,"url":null,"abstract":"<div><div>Perfluorohexane sulfonate (PFHxS) is a legacy, long-chain per- and polyfluoroalkyl substance (PFAS) frequently detected in human serum and environmental media across the globe. Previously published developmental studies in rats indicated a general lack of effects in common endpoints like maternal and offspring body and liver weights at doses up to 50 mg/kg/d. To facilitate mixture-based studies of PFAS co-exposure, individual dose response parameters are necessary for model predictions. To address these data needs we exposed timed-pregnant Sprague-Dawley rat dams to PFHxS (3–125 mg/kg/d) via oral gavage from gestation days (GD)14–18 or GD8 to postnatal day (PND)2. We evaluated a range of key events and adverse outcomes in both exposure intervals with a focus on chemical effects on serum thyroid hormone concentrations and liver toxicity. Maternal exposure from GD14–18 resulted in increased maternal liver weight (≥30 mg/kg), reduced serum total thyroxine (T4; ≥10 mg/kg) and low-density lipoprotein (LDL; ≥10 m/kg), and modest changes in maternal liver fatty acid metabolism-associated and fetal liver peroxisome proliferator-activated receptor signaling-associated gene expression. Exposure from GD8-PND2 did not affect newborn liver glycogen concentration, but did result in other neonatal effects consistent with prior PFAS studies including reduced pup survival (125 mg/kg), reduced pup bodyweight (≥62.5 mg/kg), increased pup liver weight (≥10 mg/kg), highly elevated pup serum total cholesterol and bile acids (≥3 mg/kg) and reduced serum thyroid hormones (T3, rT3, T4; ≥3 mg/kg). Maternal effects were largely limited to reductions in serum total T3 and T4 (≥10 mg/kg) and elevated serum BUN (≥62.5 mg/kg). Compared to previously published data for other PFAS, PFHxS displayed relatively low potency as a function of maternal serum concentration across a range of effects.</div></div>","PeriodicalId":23159,"journal":{"name":"Toxicology","volume":"518 ","pages":"Article 154245"},"PeriodicalIF":4.6000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0300483X25002045","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Perfluorohexane sulfonate (PFHxS) is a legacy, long-chain per- and polyfluoroalkyl substance (PFAS) frequently detected in human serum and environmental media across the globe. Previously published developmental studies in rats indicated a general lack of effects in common endpoints like maternal and offspring body and liver weights at doses up to 50 mg/kg/d. To facilitate mixture-based studies of PFAS co-exposure, individual dose response parameters are necessary for model predictions. To address these data needs we exposed timed-pregnant Sprague-Dawley rat dams to PFHxS (3–125 mg/kg/d) via oral gavage from gestation days (GD)14–18 or GD8 to postnatal day (PND)2. We evaluated a range of key events and adverse outcomes in both exposure intervals with a focus on chemical effects on serum thyroid hormone concentrations and liver toxicity. Maternal exposure from GD14–18 resulted in increased maternal liver weight (≥30 mg/kg), reduced serum total thyroxine (T4; ≥10 mg/kg) and low-density lipoprotein (LDL; ≥10 m/kg), and modest changes in maternal liver fatty acid metabolism-associated and fetal liver peroxisome proliferator-activated receptor signaling-associated gene expression. Exposure from GD8-PND2 did not affect newborn liver glycogen concentration, but did result in other neonatal effects consistent with prior PFAS studies including reduced pup survival (125 mg/kg), reduced pup bodyweight (≥62.5 mg/kg), increased pup liver weight (≥10 mg/kg), highly elevated pup serum total cholesterol and bile acids (≥3 mg/kg) and reduced serum thyroid hormones (T3, rT3, T4; ≥3 mg/kg). Maternal effects were largely limited to reductions in serum total T3 and T4 (≥10 mg/kg) and elevated serum BUN (≥62.5 mg/kg). Compared to previously published data for other PFAS, PFHxS displayed relatively low potency as a function of maternal serum concentration across a range of effects.
期刊介绍:
Toxicology is an international, peer-reviewed journal that publishes only the highest quality original scientific research and critical reviews describing hypothesis-based investigations into mechanisms of toxicity associated with exposures to xenobiotic chemicals, particularly as it relates to human health. In this respect "mechanisms" is defined on both the macro (e.g. physiological, biological, kinetic, species, sex, etc.) and molecular (genomic, transcriptomic, metabolic, etc.) scale. Emphasis is placed on findings that identify novel hazards and that can be extrapolated to exposures and mechanisms that are relevant to estimating human risk. Toxicology also publishes brief communications, personal commentaries and opinion articles, as well as concise expert reviews on contemporary topics. All research and review articles published in Toxicology are subject to rigorous peer review. Authors are asked to contact the Editor-in-Chief prior to submitting review articles or commentaries for consideration for publication in Toxicology.